Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELEVRA LITHIUM LIMITED Share Issue/Capital Change 2006

Mar 30, 2006

64838_rns_2006-03-30_58c4c39a-7972-4780-9356-56dbea0e6943.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

DIAMONEX IMITED

Sky Level 301 Coronation Drive Milton Qld 4064 Australia

Telephone: +61 7 3369-6399 Facsimile: +61 7 3369-6077 e-mail: [email protected]

Postal Address: PO Box 1357 Milton Qld 4064

ASX ANNOUNCEMENTS AUSTRALIAN STOCK EXCHANGE

31 March 2006

RELEASE OF RESTRICTED SECURITIES

Attached is an Appendix 3B applying for quotation of the following securities on expiry of the relevant restriction period:

15,107,500 fully paid ordinary shares; and $\bullet$

ABN 26 091 951 978

$\bullet$ 11,727,500 options to acquire fully paid ordinary shares, exercisable at A\$0.20, expiring 30 June 2006.

Application will also be made to list the shares on the Botswana Stock Exchange. The company's options are not listed on the Botswana Exchange.

Diamonex Limited

$64$ $4 - 4$

Paul Crawford Company Secretary

For further information, contact:

Dan O'Neill (Managing Director) $+61$ 7 33696399 (Office)

$+61$ 7 33696077 (Fax) $+61407596942$ (Mobile) diamonex $@$ diamonex.com.au (Email)

Greg King (Chairman)

+61 7 33696399 (Office) +61 7 33696077 (Fax) $+61411473730$ (Mobile) [email protected] (Email)

DiamonEx is a Brisbane-based specialist diamond company planning to develop a diamond mine based on established resources at Martin's Drift, Botswana, within an area that produces 35% of the world's diamonds by value.

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity
DIAMONEX LIMITED
ABN
26 091 951 978
We (the entity) give ASX the following information:
Part 1 - All issue
1 Class of securities issued or to be issued
2 Number of securities issued or to be issued (if
known) or maximum number which may be issued
3. Principal terms of the securities
4 Do the securities rank equally in all respects from
the date of allotment with an existing class of
quoted securities?
5 Issue price or consideration
6 Purpose of the issue
7 Dates of entering securities into uncertificated
holdings or despatch of certificates.
8 Number and class of all securities quoted on ASX Number Class
9. Number and class of all securities not quoted on
ASX.
Number Class
10 Dividend policy on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

11 Is security holder approval required?
12 Is the issue renounceable or non-renounceable?
13 Ratio in which the securities will be offered
14 Class of securities to which the offer relates
15 Record date to determine entitlements
16 Will
holdings
different
on
registers
$($ or
subregisters) be aggregated
for
calculating
entitlements?
17 Policy for deciding entitlements in relation to
fractions
18 Names of countries in which the entity has security
holders who will not be sent new issue documents
19 Closing date for receipt of acceptances or
renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or commission
22 Names of any brokers to the issue
23 Fee or commission payable to the broker to the
issue
24 Amount of any handling fee payable to brokers
who lodge acceptances or renunciations on behalf
of security holders
25 If the issue is contingent on security holders'
approval, the date of the meeting
26 acceptance form and
Date
entitlement and
prospectus or Product Disclosure Statement will be
sent to persons entitled
27 If the entity has issued options, and the terms
entitle option holders to participate on exercise, the
date on which notices will be sent to option
holders
28 Date rights trading will begin (if applicable)
29 Date rights trading will end (if applicable)
30 How do security holders sell their entitlements in
full through a broker?
  • $31$ How do security holders sell part of their entitlements through a broker and accept for the balance?
  • How do security holders dispose of th 32 entitlements (except by sale through a broker)?
  • 33 Despatch date

Part 3 - Quotation of securities

  • $34$ Type of securities (tick one)
  • $(a)$ Securities described in Part 1
  • $(b)$ $\mathbf{x}$ All other securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

If the securities are equity securities, the names of the 20 largest holders of the additional 35 securities, and the number and percentage of additional securities held by those holders If the securities are equity securities, a distribution schedule of the additional securities setting 36 out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ $10.001 - 100.000$ $100.001$ and over 37 A copy of any trust deed for the additional securities

Entities that have ticked box 34(b)

38 Number of securities for which quotation is sought 15,107,500
11,727,500
39. Class of securities for which quotation is sought fully paid ordinary shares
June 2006 options, exercisable at \$0.20, expiring 30
40 Do the securities rank equally in all respects from
the date of allotment with an existing class of
quoted securities?
YES
41 Reason for request for quotation now Release of restricted securities
Number Class
42 Number and class of all securities quoted on ASX
(including the securities in clause 38)
66,245,127 Ordinary Shares
30 441 500. Ontione
.
eir

Quotation agreement

  • $\mathbf{1}$ Quotation of our additional securities is in ASX's absolute discretion. ASX may quote the securities on any conditions it decides.
  • $\overline{2}$ We warrant the following to ASX.
  • The issue of the securities to be quoted complies with the law and is not for an illegal ٠ purpose.
  • There is no reason why those securities should not be granted quotation.
  • An offer of the securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.
  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any securities to be quoted and that no-one has any right to return any securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the securities be quoted.
  • We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the securities to be quoted, it has been provided at the time that we request that the securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the securities to be quoted under section 1019B of the Corporations Act at the time that we request that the securities be quoted.
  • $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • We give ASX the information and documents required by this form. If any information or $\overline{4}$ document not available now, will give it to ASX before quotation of the securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

$84$ $-4$

Sign here:

Date: 31 March 2006 (Director/Company Secretary)

Print name: PAUL CRAWFORD